Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study — Line Melgaard (2020) | RDL Network
Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study
Article 2020 en
Authors
LM
Line Melgaard
MJ
Martin Jensen
TO
Thure Filskov Overvad
Abstract
1 min read
When using data reflecting contemporary clinical practice, we observed markedly different risks of thromboembolism and bleeding in EHRA Type 1 and Type 2 VHD. Additionally, we observed a potential underuse of oral anticoagulation within the subgroups of AF patients with EHRA Type 1 and Type 2 VHD, underlining need for further attention on this patient group.
Discussion(0)
No comments yet. Be the first to comment.